RxDoctor Payments Data

Amit Gupta, MD

Urology · Los Angeles, CANPI 1548464332

Payments from drug & device makers

$50,277in general payments, 2019–2025

Across 132 payments — averaging $380.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$33K
  • Johnson & Johnson$12K
  • Procept Biorobotics Corporation$798
  • Gyrus ACMI, Inc.$730
  • Clinical Laserthermia Systems Americas Inc.$518
  • Medtronic$357
  • plus $3K from 22 others

What the payments were for

  • Consulting fees$11,60723%
  • Speaking & faculty fees$6,19512%
  • Grants$730%
  • Travel & lodging$7,42015%
  • Food & beverage$6,69713%
  • Education$18,28536%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical65$32,954
Johnson & Johnson(3 entities)19$12,369
Procept Biorobotics Corporation3$798
Gyrus ACMI, Inc.1$730
Clinical Laserthermia Systems Americas Inc.4$518
Medtronic3$357
Olympus America Inc.3$315
Boston Scientific4$209
Koelis Inc.1$186
Genentech, Inc.3$175
Teleflex LLC2$156
Balt USA, LLC1$155
Genentech USA, Inc.1$154
Photocure Inc1$152
Immunitybio, Inc.1$152
Telix Pharmaceuticals1$117
Convatec Inc.4$112
Angiodynamics, Inc.2$111
EDAP Technomed Inc1$100
Neuronetics, Inc.1$83
Laborie Medical Technologies Corp.2$82
Bayer1$75
Ambu Inc.2$55
Ferring Pharmaceuticals Inc.2$54
AstraZeneca1$35
Pfizer1$28
Urovant Sciences Inc1$26
ABC Home Medical Supply, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,277 in reported general payments places this provider in the 85th percentile of 1,324 urology providers in California.

See all urology providers in California

Medicare billing

Part B allowed, 2024
$572,833
Medicare patients
285
Services billed
8,652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron97$68,840
MyrbetriqMirabegron14$9,190
Tamsulosin Hcl161$1,968
Finasteride153$1,948
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$301
Oxybutynin Chloride15$124
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$82
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$65
Levofloxacin17$26

Paid to pharmacies, not to this prescriber.

Other urology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →